ChartRow logo
Share this page
HQY
$92.03-0.52%
as of close, Oct 16, 2026
☾ AH $92.03 -0.52%
PeersMRNALLYMDTUNHJNJTMO

HQY financial statements

The full income statement, balance sheet, and cash-flow statement for HealthEquity Inc. (HQY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-07 87.3M2024-10 86.7M2025-01 86.5M2025-04 86.5M2025-07 86.2M2025-10 85.4M2026-01 84.5M2026-04 83.6M2026-07 82.7M-5.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofJan 31 ’26as ofJan 31 ’25as ofJan 31 ’24as ofJan 31 ’23as ofJan 31 ’22
Revenue1.31B+9.5%1.20B+20.0%1000M+16.0%862M+13.9%757M+3.1%
913M+17.5%777M+24.8%623M+26.6%492M+15.8%425M+2.3%
Cost of revenue400M-5.3%423M+12.1%377M+1.9%370M+11.5%332M+4.3%
591M-3.9%615M+21.8%505M+4.6%483M+7.5%449M+17.7%
Research & development263M+9.6%240M+9.5%219M+13.2%193M+22.9%157M+26.1%
Selling, general & administrative120M-9.3%132M+27.6%104M+6.3%97.5M+14.1%85.4M+1.1%
General & administrative120M-9.3%132M+27.6%104M+6.3%97.5M+14.1%85.4M+1.1%
Selling & marketing95.2M+5.0%90.7M+14.5%79.3M+15.1%68.8M+17.5%58.6M+17.3%
Amortization of intangibles153M-3.2%158M+9.4%144M-3.1%149M+21.6%123M+22.6%
Provision for credit losses800K+300.0%200K-88.2%1.70M-19.0%2.10M-36.4%3.30M-2.9%
Operating income322M+98.6%162M+37.9%118M+1199.5%9.06M+137.4%-24.2M-171.3%
Interest expense57.1M-5.8%60.6M+9.3%55.5M+14.5%48.4M+32.4%36.6M+4.8%
Other non-operating income12.1M-15.5%14.3M+12.0%12.8M+906.8%1.27M+121.4%-5.93M-218.5%
Gain (loss) on equity securities——0.000.00-100.0%1.69M
Pre-tax income277M+139.1%116M+54.6%75.0M+297.0%-38.1M+42.9%-66.7M-1712.1%
Income tax62.2M+221.9%19.3M+0.0%19.3M+261.7%-12.0M+46.8%-22.5M-378.3%
Net income215M+122.5%96.7M+73.6%55.7M+313.1%-26.1M+41.0%-44.3M-601.3%
$2.46+125.7%$1.09+70.3%$0.64+306.5%-$0.31+41.5%-$0.53-541.7%
EPS (basic)$2.50+125.2%$1.11+70.8%$0.65+309.7%-$0.31+41.5%-$0.53-541.7%
Weighted-avg shares (basic)86.1M-0.8%86.9M+1.5%85.6M+1.3%84.4M+1.6%83.1M+12.0%
Weighted-avg shares (diluted)87.5M-1.5%88.8M+2.2%87.0M+3.0%84.4M+1.6%83.1M+9.8%
Balance Sheetas ofJan 31 ’26as ofJan 31 ’25as ofJan 31 ’24as ofJan 31 ’23as ofJan 31 ’22
512M+7.2%478M-14.3%557M+45.6%383M+9.0%351M-23.7%
Cash & equivalents319M+7.8%296M-26.7%404M+58.9%254M+12.8%225M-31.4%
Accounts receivable124M+4.8%118M+12.5%105M+8.3%96.8M+10.8%87.4M+20.1%
Prepaid expenses69.7M+9.2%63.8M———
Other current assets—63.8M+31.4%48.6M+52.8%31.8M-17.4%38.5M-34.3%
3.38B-2.0%3.45B+9.0%3.16B+2.4%3.09B-0.6%3.11B+14.6%
Property, plant & equipment3.18M-1.9%3.24M-46.1%6.01M-53.2%12.9M-45.0%23.4M-19.7%
Operating lease right-of-use36.3M-15.9%43.2M-10.7%48.4M-14.3%56.5M-11.2%63.6M-28.9%
Goodwill1.65B+0.0%1.65B+0.0%1.65B+0.0%1.65B+0.1%1.65B+24.0%
Intangible assets1.10B-8.9%1.20B+44.1%836M-10.7%936M-3.8%973M+26.9%
Other non-current assets83.2M+16.3%71.6M+5.5%67.9M+30.1%52.2M+4.8%49.8M+33.1%
157M+0.3%156M+33.5%117M-10.7%131M-14.4%153M-25.2%
Accounts payable12.2M-15.3%14.4M+19.3%12.0M-13.4%13.9M-49.5%27.5M+1606.4%
Accrued liabilities74.4M+18.8%62.6M+36.0%46.0M+5.4%43.7M-24.2%57.6M-24.1%
Short-term & current debt0.000.000.00-100.0%17.5M+100.0%8.75M-86.0%
Current lease liability9.91M-0.9%10.0M+6.3%9.40M-7.4%10.2M-16.5%12.2M-13.3%
1.27B-4.5%1.33B+18.1%1.13B-5.4%1.19B-4.9%1.25B-5.8%
Long-term debt957M-9.4%1.06B+20.7%875M-3.6%908M-1.5%922M-0.2%
Non-current lease liability34.2M-19.0%42.2M-13.4%48.8M-17.3%59.0M-9.6%65.2M-12.1%
Operating lease liability (total)44.1M-15.5%52.2M-10.2%58.2M-15.9%69.1M-10.7%77.4M-12.3%
Deferred tax liabilities93.7M+67.8%55.8M-18.7%68.7M-16.9%82.7M-17.2%99.8M-16.6%
Other non-current liabilities31.0M+35.0%23.0M+19.2%19.3M+51.6%12.7M-10.4%14.2M+61.0%
Total non-current liabilities1.12B-5.2%1.18B+16.4%1.01B-4.8%1.06B-3.6%1.10B-2.3%
2.11B-0.4%2.11B+3.9%2.04B+7.4%1.90B+2.3%1.85B+34.4%
Preferred stock0.000.000.000.000.00
Common stock8.00K-11.1%9.00K+0.0%9.00K+12.5%8.00K+0.0%8.00K+0.0%
Additional paid-in capital1.92B+0.6%1.91B+4.2%1.83B+4.8%1.75B+4.1%1.68B+44.7%
Retained earnings196M-6.4%209M+1.8%206M+37.2%150M-14.8%176M-20.1%
Accumulated other comprehensive income-5.71M0.00———
Total liabilities & equity3.38B-2.0%3.45B+9.0%3.16B+2.4%3.09B-0.6%3.11B+14.6%
Common shares issued85.0M-1.8%86.5M+0.5%86.1M+1.6%84.8M+1.2%83.8M+8.6%
Common shares outstanding85.0M-1.8%86.5M+0.5%86.1M+1.6%84.8M+1.2%83.8M+8.6%
Shares outstanding (cover)84.5M-2.3%86.5M+0.4%86.2M+1.6%84.8M+1.1%83.8M+1.0%
Cash Flowas ofJan 31 ’26as ofJan 31 ’25as ofJan 31 ’24as ofJan 31 ’23as ofJan 31 ’22
457M+34.5%340M+40.0%243M+61.2%151M+6.8%141M-22.4%
Depreciation & amortization155M-4.8%162M+6.1%153M-5.0%161M+17.5%137M+18.4%
Intangible amortization153M-3.2%158M+9.4%144M-3.1%149M+21.6%123M+22.6%
Share-based compensation73.1M-24.2%96.4M+25.0%77.2M+23.2%62.6M+18.7%52.8M+23.1%
Deferred income taxes39.8M+409.9%-12.8M+8.3%-14.0M+18.5%-17.2M+26.3%-23.3M-354.3%
Change in receivables5.69M-56.6%13.1M+62.7%8.06M-15.8%9.57M-14.6%11.2M+2612.8%
-47.1M+90.7%-505M-997.0%-46.1M+61.3%-119M+81.4%-639M-559.3%
Capital expenditure1.97M-5.5%2.08M+23.0%1.69M-49.7%3.37M-62.2%8.91M-32.0%
Free cash flow455M+34.7%338M+40.1%241M+63.7%147M+11.5%132M-21.6%
Acquisitions0.000.000.000.00-100.0%505M
Purchases of investments
————0.00
-387M-772.2%57.6M+222.4%-47.0M-1661.1%-2.67M-100.7%395M+653.2%
Long-term debt issued0.00-100.0%737M0.000.00-100.0%950M
Long-term debt repaid100M-82.2%562M+933.3%54.4M+521.4%8.75M-99.1%1.00B+319.6%
Common stock issued0.000.000.000.00-100.0%457M+59.2%
Common stock repurchased299M+146.3%121M0.000.000.00
Dividends paid0.000.000.000.000.00
Net change in cash23.0M+121.3%-108M-172.2%150M+418.9%28.9M+127.9%-103M-175.4%
Interest paid52.2M-10.8%58.6M+18.2%49.6M+13.7%43.6M+170.5%16.1M-41.8%
Income taxes paid8.04M-69.2%26.1M-26.3%35.4M+2216.6%1.53M+127.1%-5.63M+6.5%
Valuation Ratiosas ofJan 31 ’26as ofJan 31 ’25as ofJan 31 ’24as ofJan 31 ’23as ofJan 31 ’22
Market cap7.32B-23.4%9.55B+46.7%6.51B+26.2%5.16B+15.2%4.48B-30.4%
P/E38.2×-61.4%98.8×-15.5%116.9×——
P/S5.7×-28.8%8.0×+22.2%6.5×+8.8%6.0×+1.1%5.9×-31.3%
P/B3.4×-24.1%4.5×+41.1%3.2×+17.6%2.7×+12.6%2.4×-49.1%
P/FCF17.7×-37.3%28.3×+4.7%27.0×-22.9%35.0×+3.3%33.9×-27.2%
Earnings yield2.6%+158.8%1.0%+18.3%0.86%——
FCF yield5.6%+59.5%3.5%-4.5%3.7%+29.7%2.9%-3.2%2.9%+37.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: HQY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HQY filings on SEC EDGAR → Not investment advice.